Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status - PMC
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. 1Department of Neurology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 77900 Olomouc, Czech Republic; zc.lonf@avokisnem.aniretak (K.M.); zc.lonf@avokcut.eicul (L.T.); zc.murtnec@ave.avokyneh (E.H.); zc.lopu@danrts.valsorim (M.S.); zc.onf@laksjets.divad (D.S.); zc.lonf@yksvonak.rtep (P.K.) 1Department of Neurology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 77900 Olomouc,
Biomedicines . 2022 Jul 21;10(7):1760. doi: 10.3390/biomedicines10071760 Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status Dorota Koníčková Dorota Koníčková 1 Department of Neurology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 77900 Olomouc, Czech Republic; katerina.mensikova@fnol.cz (K.M.); lucie.tuckova@fnol.cz (L.T.); henykova.eva@centrum.cz (E.H.); miroslav.strnad@upol.cz (M.S.); david.stejskal@fno.cz (D.S.); petr.kanovsky@fnol.cz (P.K.) Find articles by Dorota Koníčková 1, * , Kateřina M
Explore this link on the map →related reading
- Biomarkers for Parkinson’s Disease: How Good Are They? - PMCpmc.ncbi.nlm.nih.gov
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- Blood biomarkers in ALS: challenges, applications and novel frontiers - PMCncbi.nlm.nih.gov
- Diagnostic biomarkers for Parkinson’s disease at a glance: where are we? | Journal of Neural Transmission | Springer Nature Linklink.springer.com
- Diagnostic biomarkers for Parkinson’s disease at a glance: where are we? | Journal of Neural Transmission | Springer Nature Linklink.springer.com
- Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research | Metabolic Brain Disease | Springer Nature Linklink.springer.com
- Parkinson’s Disease and Parkinsonism: Neuropathology - PMCpmc.ncbi.nlm.nih.gov
- Brain Imaging in Differential Diagnosis of Dementiapracticalneurology.com
- Biomarkers for Parkinson’s Disease: How Good Are They? | Neuroscience Bulletin | Springer Nature Linklink.springer.com
- Sonja W. Scholz, M.D., Ph.D. | Principal Investigators | NIH Intramural Research Programirp.nih.gov
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study - PMCpmc.ncbi.nlm.nih.gov